1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Glycemic and non-glycemic effects of pioglitazone in triple oral therapy in patients with type 2 diabetes mellitus
(
- Contribution to journal › Article
- 2005
-
Mark
Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
(
- Contribution to journal › Article
- 2004
-
Mark
Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
(
- Contribution to journal › Article
-
Mark
Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease.
(
- Contribution to journal › Article
- 1997
-
Mark
Cystatin C, and inhibitor of bone resorption produced by osteoblasts
(
- Contribution to journal › Article
-
Mark
Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases
(
- Contribution to journal › Article
- 1992
-
Mark
Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy
(
- Contribution to journal › Article
- 1983
-
Mark
Occurrence of gamma-trace in the calcitonin-producing C-cells of simian thyroid gland and human medullary thyroid carcinoma
(
- Contribution to journal › Article